Application
Immunofluorescence analysis of HeLa cells, using Kv3.4/KCNC4 (Ab-15) Antibody. The picture on the right is treated with the synthesized peptide.Application
Immunohistochemistry analysis of paraffin-embedded human brain, using Kv3.4/KCNC4 (Ab-15) Antibody. The picture on the right is treated with the synthesized peptide.Application
Western blot analysis of extracts from COS7 cells treated with Anisomycin 25ug/ml 30', using Kv3.4/KCNC4 (Ab-15) Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | Kv3.4/KCNC4 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to Kv3.4/KCNC4This protein mediates the voltage-dependent potassium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a potassium-selective channel through which potassium ions may pass in accordance with their electrochemical gradient. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human KCNC4. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFIHCIHC-PWB |
| IHC: 1:50~1:100 : |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | KSHIIIC KCNC4 potassium channel Kv3.4 potassium voltagegated channel subfamily C member4 potassium voltagegated channel subfamily C member 4 Kv3.4/KCNC4 potassium voltage-gated channel subfamily C member 4 |
|---|---|
| Target | Kv3.4/KCNC4 |
| Molecular Weight(MW) | 69 kDa (note) |
| Tissue Specificity | Kv3.4/KCNC4 (Ab-15) Antibody detects endogenous levels of total Kv3.4/KCNC4 protein. |
Application
Immunofluorescence analysis of HeLa cells, using Kv3.4/KCNC4 (Ab-15) Antibody. The picture on the right is treated with the synthesized peptide.
Application
Immunohistochemistry analysis of paraffin-embedded human brain, using Kv3.4/KCNC4 (Ab-15) Antibody. The picture on the right is treated with the synthesized peptide.
Application
Western blot analysis of extracts from COS7 cells treated with Anisomycin 25ug/ml 30', using Kv3.4/KCNC4 (Ab-15) Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | IHC: 1:50~1:100 : |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 67% glycerol. |
